-
Pharmacology
-
- Enzymes
-
- ATPase & GTPase
- Caspase
- Cholinesterase
- Coenzymes
- Cyclase
- Cyclooxygenase
- Cytochrome P450
- Deacetylase
- Dehydrogenase
- Demethylase
- Hydrolase
- Isomerase
- Kinase
- Oxidases
- Oxygenase
- Phosphatase
- Phosphodiesterase
- Phospholipase & Lipase
- Polymerase
- Protease
- Reductase
- Secretase
- Synthetase & synthase
- Telomerase
- Transaminase
- Transferase
- Ion Channels
- Receptors & Transporters
-
- Adenosine
- Adrenoceptors
- Cannabinoid
- Catalytic Receptors
- Chemokine
- Dopamine
- Enzyme-Linked Receptors
- G protein-coupled estrogen
- GABA
- Glutamate
- Glycine
- Histamine
- Imidazoline
- Inositol triphosphate receptor
- Melatonin
- Muscarinic
- Nicotinic
- Nuclear Receptors
- Opioids
- Peptide Receptors
-
- Angiotensin
- Apelin
- AXOR
- Bombesin
- Bradykinin
- CCK
- Endothelin
- Galanin
- Ghrelin
- Glucagon and Related Receptors
- LHRH
- Melanocortin
- Melanocyte Stimulating Hormone
- Motilin
- Neuromedin
- Neuropeptide FF/AF Receptors
- Neuropeptide S
- Neuropeptide Y
- Neurotensin
- Orexin
- Other
- Oxytocin
- PAR
- Secretin receptor
- Sensory Neuron Specific Receptor
- Somatostatin
- Substance P
- Tachykinins
- Vasopressin
- VIP
- Prostanoid
- Purinergics
- Serotonin
- Sigma
- Smoothened
- Sphingosine 1-Phosphate Receptors
- TGR5
- Toll-like Receptors
- Transporters
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Epigenetics
- Extracellular matrix & cell adhesion
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
-
Research Area
-
- Addiction
- Alzheimer's Disease
-
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Muscarinic
- Nicotinic
- Nitric oxide signaling
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Cancer
-
- Angiogenesis
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Epigenetics
- Extracellular matrix & cell adhesion
- Nuclear Receptors
- Signal transduction
- Depression
- Diabetes
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Heart disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Calcium
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Hypertension
-
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Obesity
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Serotonin
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Pain & inflammation
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- GABA
- Glutamate
- Histamine
- Immunomodulators
- Nitric oxide signaling
- Opioids
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Parkinson's Disease
- Respiratory disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Histamine
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Schizophrenia
- Stress / Anxiety
- - Stroke
-
- Adenosine
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
We have 484 products in: Biochemicals >> Research Area >> Stroke
Stroke beginning with J - N |
| J - N page: 1 2 |
Code | Name | Details | Image Abreview Publication |
|---|---|---|---|
| Smoothened inhibitor Purity: > 98% |   | ||
| Highly potent inhibitor of protein and CAM kinases Purity: > 99% | | ||
| Phytoestrogen. Proapoptotic agent. Purity: > 98% | | ||
| Prototypic kainate receptor agonist. Purity: > 99% |  | ||
| Promotes differentiation of human mesenchymal stems cells into chondrocytes Purity: > 98% | | ||
| NCX inhibitor. TRPC blocker. Purity: > 99% | | ||
| Highly potent COX1/2 inhibitor. Non-steroidal anti-inflammatory drug (NSAID). Purity: > 98% | | ||
| CaM kinase II inhibitor. P2X7 antagonist. Purity: > 98% |  | ||
| Potent, specific CaMK II inhibitor Purity: > 99% | | ||
| Endogenous ionotropic / nicotinic antagonist Purity: > 99% | | ||
| Endogenous ionotropic / nicotinic antagonist; water soluble Purity: > 99% | | ||
| Potent and selective γ-secretase inhibitor Purity: > 98% | | ||
| Topoisomerase I inhibitor Purity: > 98% | | ||
| Potent EGF receptor tyrosine kinase inhibitor Purity: > 98% | | ||
| Antibiotic, antifungal. Inhibitor of CRM-1 mediated nuclear export. Purity: > 98% | | ||
| Highly potent, reversible, selective aromatase inhibitor Purity: > 99% | | ||
| KATP channel activator. Purity: > 99% | | ||
| GSK-3β inhibitor Purity: > 99% | | ||
| Nitric oxide synthase inhibitor Purity: > 99% | | ||
| Potent HMG CoA reductase inhibitor Purity: > 98% | | ||
| Antioxidant, anti-inflammatory, anti-cancer flavonoid Purity: > 99% | | ||
| Water-soluble group II/group III mGlu antagonist. Disodium salt of LY 341495 ( Purity: > 98% | | ||
| PI3-kinase inhibitor Purity: > 99% | | ||
| Potent, selective group II antagonist. Group III antagonist at higher concentrations. Purity: > 98% | | ||
| Water-soluble, potent, selective group II antagonist. Group III antagonist at higher concentrations. Purity: > 98% | | ||
| Group II mGlu agonist. Systemically active. Purity: > 98% | | ||
| mGlu1a antagonist Purity: > 99% | | ||
| Group II mGlu agonist. Systemically active. Purity: > 99% | | ||
| mGlu1 non competitive antagonist Purity: > 99% | | ||
| Group I /II metabotropic glutamate antagonist Purity: > 99% | | ||
| Group I / II mGlu antagonist Purity: > 98% | | ||
| Group I /II metabotropic glutamate antagonist; water soluble Purity: > 99% | | ||
| NMDA antagonist, ion channel site Purity: > 98% | | ||
| Phosphatase inhibitor; vitamin K prodrug Purity: > 99% | | ||
| Selective iNOS inhibitor; peroxynitrite scavenger | | ||
| A myristate analog. Shows antiviral activity. Purity: > 99% | | ||
| Potent antitumor and antiangiogenic agent Purity: > 98% | | ||
| Anti-arrthymic Purity: > 99% | | ||
| Potent HMG-CoA reductase inhibitor Purity: > 98% | | ||
| HMG-CoA reductase inhibitor Purity: > 98% | | ||
| mGlu Agonists Kit |
| | |
| mGlu Antagonists Kit |
| | |
| PR and GR antagonist Purity: > 98% | | ||
| Antibiotic. Demonstrates multiple effects. Purity: > 99% | | ||
| MRN-ATM complex inhibitor Purity: > 99% | | ||
| Cell permeable dynamin I and dynamin II inhibitor | | ||
| Anti-cancer and antibiotic agent Purity: > 99% | | ||
| Non-competitive NMDA antagonist Purity: > 99% | | ||
| Non competitive NMDA antagonist; less active enantiomer Purity: > 99% | | ||
| Potent lipoxygenase inhibitor Purity: > 98% | | ||
| mGlu7 allosteric antagonist Purity: > 98% | | ||
| Selective JAK2 inhibitor Purity: > 95% | | ||
| Potent and cell permeable mitosis inhibitor. Kinesin Eg5 inhibitor. Purity: > 99% | | ||
| Na+ ionophore Purity: > 95% | | ||
| NOS inhibitor Purity: > 99% | | ||
| Vasodilator. Active metabolite of molsidomine. Purity: > 98% | | ||
| Potent, selective mGlu5 antagonist Purity: > 99% | | ||
| Selective A2B antagonist Purity: > 98% | | ||
| Novel, high affinity smoothened (Smo) antagonist Purity: > 99% | | ||
| Potent, selective mGlu5 antagonist Purity: > 99% | | ||
| Immunosuppressant. Inosine monophosphate dehydrogenase inhibitor. Purity: > 99% | | ||
| Potent anti-neoplastic, anti-oxidant and anti-inflammatory agent Purity: > 97% | | ||
| Endogenous CB1 / TRPV1 agonist Purity: > 98% | | ||
| Non-selective COX inhibitor Purity: > 99% | | ||
| AMPA / kainate antagonist Purity: > 98% | | ||
| AMPA / kainate antagonist; water soluble Purity: > 98% | | ||
| Highly potent adenosine agonist Purity: > 99% | | ||
| Fluorescent non-selective adenosine agonist Purity: > 97% | | ||
| Potent, specific necroptosis inhibitor Purity: > 99% | | ||
| Induces neurogenesis in skeletal muscle cells Purity: > 98% | | ||
| Control peptide for ( Purity: > 94% | | ||
| Competes with AP-2 binding to NR2B Purity: > 95% | | ||
| L-type Ca2+ channel antagonist Purity: > 99% | | ||
| Amide form of vitamin B3 Purity: > 99% | | ||
| Antidyslipidemic agent Purity: > 98% | |